Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Sention Inc
Profile last edited on: 12/22/2014      CAGE: 3K1Q8      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1999
First Award
2002
Latest Award
2004
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

1 Richmond Square Floor 3
Providence, RI 02906
   (401) 272-7177
   N/A
   N/A
Location: Single
Congr. District: 01
County: Providence

Public Profile

Sention was focused on the discovery, development and marketing of drugs for the treatment of disorders related to higher brain functions such as learning and memory. Sention ceased operations in June 2005.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
1
Conversion Rate
100.00%
Phase I Dollars
$99,348
Phase II Dollars
$754,672
Total Awarded
$854,020

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2004 2 NIH $854,020
Project Title: New Computerized Test for Memory Trials

Key People / Management

  Mel H Epstein

  H E Mel

Company News

There are no news available.